The Relationship Between the Expression of circFAT1 and Immune Cell in Patients with Non-Small Cell Lung Cancer

被引:0
|
作者
Li, Jingjing [1 ]
Liu, Yabing [1 ]
Zeng, Wenxuan [2 ]
Wu, Yanrun [3 ]
Ao, Wei [4 ]
Yuan, Xiwei [1 ]
Zhou, Chuanyi [1 ]
机构
[1] Yueyang Peoples Hosp, Dept Oncol, 263 Baling East Rd, Yueyang City 414000, Hunan, Peoples R China
[2] Yueyang Cent Hosp, Dept Cardiovasc, Yueyang City 414000, Hunan, Peoples R China
[3] Yueyang Cent Hosp, Dept Ultrason, Yueyang City 414000, Hunan, Peoples R China
[4] Yueyang Peoples Hosp, Dept Cardiovasc, Yueyang City 414000, Hunan, Peoples R China
关键词
non -small cell lung cancer; circFAT1; immune microenvironment; correlation;
D O I
10.2147/IJGM.S434065
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To analyze the correlation between the expression of circFAT1 in serum and immune cells in patients with non-small cellMethods: A total of 96 patients with NSCLC admitted to our hospital from November 2019 to November 2022 were regarded as the study subjects. In the meantime, 96 volunteers who had physical examination in our hospital were regarded as the control group. The expression level of circFAT1 in serum was detected by real-time fluorescence quantitative PCR. NSCLC cancer tissue (NSCLC group) and paracancerous tissue (tissue >= 2cm away from the focus) (paracancerous group) were collected during the operation, the expression of CD4+, CD8+ and Foxp3+ in tissues was determined by immunohistochemistry; the expression level of circFAT1 mRNA in NSCLC tissue was analyzed using the Ualcan database. Spearman correlation was applied to analyze the correlation between the expression of circFAT1 and immune cells (CD4+, Foxp3+, CD8+).Results: The level of circFAT1 in NSCLC tissue was higher than that in normal tissue (P < 0.05). Compared with the control group, the expression level of circFAT1 in serum of NSCLC group was obviously higher (P < 0.05). The expression level of circFAT1 was related to lymph node metastasis, TNM stage and differentiation (P < 0.05). Compared with the paracancerous group, the positive expression rate of CD8+ in NSCLC group was obviously lower, and the positive expression rates of CD4+ and Foxp3+ were obviously higher (P < 0.05). The expression of CD4+, Foxp3+ and CD8+ in NSCLC patients' cancer tissue was related to lymph node metastasis, TNM stage and differentiation degree (P < 0.05). Spearman correlation analysis showed that circFAT1 was positively correlated with the expression of CD4+ and Foxp3+ and negatively correlated with the expression of CD8+ (P < 0.05).Conclusion: CircFAT1 is highly expressed in the serum of NSCLC patients and is closely related to immune cells.
引用
收藏
页码:4943 / 4951
页数:9
相关论文
共 50 条
  • [41] Immune checkpoint pathways in non-small cell lung cancer
    Chae, Young Kwang
    Arya, Ayush
    Iams, Wade
    Cruz, Marcello
    Mohindra, Nisha
    Villaflor, Victoria
    Giles, Francis J.
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (05)
  • [42] Immune Checkpoint Modulation for Non-Small Cell Lung Cancer
    Soria, Jean-Charles
    Marabelle, Aurelien
    Brahmer, Julie R.
    Gettinger, Scott
    CLINICAL CANCER RESEARCH, 2015, 21 (10) : 2256 - 2262
  • [43] Difference in Benefit of Chemotherapy Between Small Cell Lung Cancer Patients with Interstitial Pneumonia and Patients with Non-small Cell Lung Cancer
    Kashiwabara, Kosuke
    Semba, Hiroshi
    Fujii, Shinji
    Tsumura, Shinsuke
    Aoki, Ryota
    ANTICANCER RESEARCH, 2015, 35 (02) : 1065 - 1071
  • [44] Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
    Herzberg, Benjamin
    Campo, Meghan J.
    Gainor, Justin F.
    ONCOLOGIST, 2017, 22 (01): : 81 - 88
  • [45] Immune Checkpoint Therapy in Non-Small Cell Lung Cancer
    Marrone, Kristen A.
    Brahmer, Julie R.
    CANCER JOURNAL, 2016, 22 (02): : 81 - 91
  • [46] Immune checkpoint inhibitors in non-small cell lung cancer
    Eberhardt, Wilfried Ernst Erich
    ONKOLOGE, 2017, 23 (10): : 838 - 844
  • [47] Prognostic Immune Markers in Non-Small Cell Lung Cancer
    Suzuki, Kei
    Kachala, Stefan S.
    Kadota, Kyuichi
    Shen, Ronglai
    Mo, Qianxing
    Beer, David G.
    Rusch, Valerie W.
    Travis, William D.
    Adusumilli, Prasad S.
    CLINICAL CANCER RESEARCH, 2011, 17 (16) : 5247 - 5256
  • [48] Correlation between survivin expression and prognosis in non-small cell lung cancer
    Atikcan, Sukran
    Unsal, Ebru
    Demirag, Funda
    Koksal, Deniz
    Yilmaz, Aydin
    RESPIRATORY MEDICINE, 2006, 100 (12) : 2220 - 2226
  • [49] Expression of CXCL8 and its relationship with prognosis in patients with non-small cell lung cancer
    Ma, Xuan
    Zhu, Xuean
    Zou, Mingli
    Zhang, Jingjing
    Huang, Lili
    Jiang, Shasha
    Zhi, Yanan
    AMERICAN JOURNAL OF CANCER RESEARCH, 2024, 14 (06): : 2934 - 2945
  • [50] Correlation between survivin expression and prognosis in non-small cell lung cancer
    Atikcan, S
    Ünsal, E
    Demirag, F
    Köksal, D
    Yilmaz, A
    CHEST, 2005, 128 (04) : 332S - 332S